Ian Pearce Screenshot

Faricimab - all you need to know about the new treatment for wet AMD and DMO

Posted: Tuesday 30 August 2022

"There's a long way to go but I'm more optimistic. I was thinking of retiring a few years ago, now I'm so excited about the treatments we can offer patients I'll probably stay another few years."

Find out more

Drug Vial close up

Thousands of patients with diabetes-related sight loss given access to new treatment

Posted: Thursday 11 August 2022

Thousands of patients with diabetic macular oedema (DMO) could benefit from a steroid treatment, which has previously only been available to those who have received cataract surgery.

Find out more

Gareth portrait

"It could be life-changing for so many people"

Posted: Wednesday 3 August 2022

A 75-year-old man involved in a clinical trial for a new implant for wet age-related macular degeneration (AMD) says it would be ‘magic’ if the trial is successful.

Find out more

Ian Pearce Portrait

Ophthalmologist to reveal more about new drug for two types of macular disease

Posted: Wednesday 3 August 2022

An ophthalmologist who has worked on the clinical trials for the latest drug approved to treat wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO) will reveal more about the treatment and how you can access it, as part of the Macular Society’s monthly webinar series.

Find out more

Nurse and patient smiling

New treatment option approved for patients with diabetic macular oedema

Posted: Thursday 28 July 2022

Patients living with diabetes-related sight loss could be treated with a new drug, following a recommendation from The National Institute for Health and Care Excellence (NICE).

Find out more

Scientist with drug vial

Cheaper drugs for wet AMD becoming available on the NHS

Posted: Tuesday 19 July 2022

New forms of anti-VEGF drugs will soon be available to treat wet age-related macular degeneration (AMD) thanks to the production of biosimilars.

Find out more

Researcher Amanda Carr with Bunson Burner

Gene editing to treat inherited macular disease

Posted: Tuesday 5 July 2022

A research team is making strides in using gene-editing techniques to treat a rare, inherited form of macular disease.

Find out more

Zebra fish

Could zebrafish speed up macular research?

Posted: Thursday 30 June 2022

Scientists at the University of Sussex are looking into whether cells from the zebrafish eye can be manipulated to create a macula, which could be used in future research.

Find out more

A field of pink and purple hyacinths

Creating a wet AMD drug using flower compounds

Posted: Monday 20 June 2022

Scientists working to unleash the power of the well-renowned hyacinth plant have revealed more about their work to beat macular disease.

Find out more

Professor Dulcie Mulholland in her lab smiling

Do plants hold the power to cure macular disease?

Posted: Monday 20 June 2022

Professor Dulcie Mulholland is studying the family of the hyacinth to find a new treatment for macular disease. Find out why she thinks plants could hold the answers we're looking for.

Find out more

Scientist in laboratory

New drug for Stargardt could reach patients faster

Posted: Friday 17 June 2022

A new drug to treat Stargardt disease has been granted a fast-track review by the Food and Drug Administration in the US, to help make it available to patients quicker.

Find out more

Eye drops being instilled into patient by professional with blue gloves.

New treatment approved for wet AMD and diabetic macular oedema

Posted: Tuesday 24 May 2022

A new treatment for wet AMD and diabetic macular oedema Faricimab has been approved for use on the NHS in England.

Find out more